A new report out today from the Food and Drug Administration (FDA) fails to offer a concrete plan on how the Agency will regulate CBD products. Congress instructed the FDA in last year’s spending bill to adopt an enforcement discretion policy…
The Food and Drug Administration (FDA) failed to meet its deadline to provide a Congressionally mandated report on how it plans to regulate CBD. Congress instructed the FDA in last year’s spending bill to adopt an enforcement discretion policy…
Companies producing and selling hemp-derived CBD products would have access to essential banking services under new legislation introduced today in the New Jersey State Senate. The legislation, introduced by State Senator Robert W. Singer (R-NJ-30), would clarify that banks…
NPA today rejected a bill proposed in the Illinois state legislature that would prohibit the sale of CBD products that do not meet certain requirements set by the Illinois Department of Agriculture.
The NPA Awards salute industry pioneers and leaders for their accomplishments in science, environmental issues, advocacy, social responsibility, and the industry at large.
